Guanidinylated 2,5-dideoxystreptamine Derivatives As Anthrax Lethal Factor Inhibitors
Overview
Affiliations
Anthrax lethal factor is a Zn(2+)-dependent metalloprotease and the key virulence factor of tripartite anthrax toxin secreted by Bacillus anthracis, the causative agent of anthrax. A series of guanidinylated 2,5-dideoxystreptamine derivatives were designed and synthesized as inhibitors of lethal factor, some of which show strong inhibitory activity against lethal factor in an in vitro FRET assay. Preparation and structure-activity relationships of these compounds are presented.
Furin-mediated protein processing in infectious diseases and cancer.
Braun E, Sauter D Clin Transl Immunology. 2019; 8(8):e1073.
PMID: 31406574 PMC: 6682551. DOI: 10.1002/cti2.1073.
Suryadi K, Shine N PLoS One. 2018; 13(11):e0207084.
PMID: 30412638 PMC: 6226181. DOI: 10.1371/journal.pone.0207084.
Zhang X, Amin E J Mol Graph Model. 2015; 63:22-8.
PMID: 26615468 PMC: 4713341. DOI: 10.1016/j.jmgm.2015.11.008.
Ramos-Molina B, Lick A, Blanco E, Posada-Salgado J, Martinez-Mayorga K, Johnson A Biochem Pharmacol. 2015; 96(2):107-18.
PMID: 26003844 PMC: 4468025. DOI: 10.1016/j.bcp.2015.05.008.
Small molecule inhibitors of anthrax lethal factor toxin.
Williams J, Khan A, Cardinale S, Butler M, Bowlin T, Peet N Bioorg Med Chem. 2013; 22(1):419-34.
PMID: 24290062 PMC: 3925373. DOI: 10.1016/j.bmc.2013.11.009.